Datasetsmetadata only
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
19,622Documents
0Full text
2026-09-07Last indexed
Recent documents from this source
- Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma#467628
- Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates#467627
- Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.#467626
- Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination#467625
- To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen#467624
- Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine#467623
- Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).#467622
- First-in-human Study of S-588210 (S-488210+S-488211)#467621
- A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children#467620
- Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response#467619
- HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia#467618
- Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection#467617
- Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines#467616
- Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer#467615
- Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease#467614
- A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health#467613
- Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds#467612
- Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population#467611
- Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial#467610
- Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above#467609
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).